Central Life Sciences is dedicated to improving the health, well-being, and the protection of companion animals, economic animals, plants, stored grains and the environment. The technical and active ingredient business provides products to a broad range of consumer and B2B customers allowing them to formulate a range of pet care and household products. Responsible for developing and implementing strategic and product development plans, achieving annual business goals of revenue, profit, and share growth, and championing cross-functional projects.

Grew share by >2% over market by leading growth initiatives (new product commercialization, geographic expansion, and promotional efforts). Expanded sales through distribution by 3% by selecting new channel partners, and enhanced product training. Concurrently responsible for product portfolio analysis to drive product line simplification and targeted pricing and margin improvement opportunities. Responsible for global product line profitability, new product commercialization, marketing communications and project management.

Seeking to leverage my experience in Project Management, Strategic Marketing and commercializing new technology to obtain a new full-time position.

Managed a portfolio of complex multidisciplinary projects, total value $50M. Coordinated headcount and capital budget of $5M across Marketing, Sales, Regulatory, R&D and Engineering. • Achieved project milestones on schedule and within budget for a variety of specialty materials for medical device applications• Maintained rapport with Technical Director and Product Development Program Manager at world leading Wound Care company, regularly communicating project status and resolving technical issues.• Presented Business Case to Healthcare Board for initial and ongoing investment approvals

Lead Cost Analyst for the largest capital project in company history - $1.2B.• Implemented capital project cost model to manage estimates, bids and actual spending across 5 engineering firms over 4 project phases concurrently. • Created complex sensitivity spreadsheet models to support BOD capital requests and project updates. Regular interactions with director level on decision support.• Successfully managed relationship with several Engineering Firms on all cost related matters.• Developed process and tools for Physical Progress, Change Control and Risk Management.

Evaluated market potential of new technologies across a diverse mix of markets, applications and Business Units. Led cross-functional teams to develop business opportunities. Analyzed market segmentation, interviewed market participants to validate unmet needs, developed value propositions and business models to capture value.• Developed a portfolio of projects valued at over $40M across diverse applications: Sol-Gel technology for coating applications. Encapsulation and controlled release technology for Personal and Health Care. Oxygen Transfer Agents for Bioprocessing. Resin technology for Architectural and Coil Coatings. Filler treatments for Plastics.• Selected to pilot new Innovation Commercialization process with Harvard Business School consultants.

Transformed the value capture model in Asia from a traditional ‘product only’ business model to a bundled services model. Created infrastructure (policy, training, metrics, procedures) to institutionalize the services model throughout Asia.• By working closely with each Industry Group across the Region, revenue was doubled in 2 years (from $33M in 2005 to $64M in 2006).• Exceeded Asia sales plan by 32%, and Global plan by 41%• Led a cross-Industry team to develop new business models to analyze local Chinese competitors.

Implemented the Corporate Strategic Planning process in support of CEO direction. Facilitated Executive Leadership to create a Corporate plan to be expressed by business, leading to profitability targets by business. • Developed process to re-allocate $45M from Mature to Growth businesses.• Created process to rationalize non-essential services, resulting in reduction of $120M of non-product costs.• Developed model to simulate exchange rate scenarios and their impact on EBIT.• Created an Enterprise-wide project prioritization system to allow aggregation and trade-off decisions by the Executive Committee.• Two-time winner of the CFO Award for high-impact projects

• Commercialization Process Implementation Team• Supply Chain Analyst• Technical Service & Development – Textile & Nonwoven Industry• Product Steward – Aminofunctional Siloxanes• Economic Evaluation – Greases & Lubricants• Operations Leader• Manufacturing Engineer• Pilot Plant Engineer